Literature DB >> 24106902

Pigmented villonodular synovitis: current concepts about diagnosis and management.

Floortje G M Verspoor1, Ingrid C M van der Geest, Erik Vegt, Rene P H Veth, Winette T van der Graaf, H W Bart Schreuder.   

Abstract

At present, the treatment strategies in patients with localized and diffuse forms of pigmented villonodular synovitis have more or less been standardized. However, these strategies are not optimal because high recurrence rates persist and studies with a sufficient level of evidence are lacking. This systematic review article describes all known treatment options for intra-articular pigmented villonodular synovitis and their clinical results. Based on this research, we provide guidelines to support physicians in making the optimal treatment decisions. Given the rarity of the disease, randomized studies are not to be expected, but an international registry through existing networks would offer the benefit of getting a better insight into the outcome of this disease. Therefore, we propose a basic set of data to be investigated and ideally to be reported on in such a registry.

Entities:  

Mesh:

Year:  2013        PMID: 24106902     DOI: 10.2217/fon.13.124

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  9 in total

1.  Immune Cell Infiltration Characteristics of Pigmented Villous Nodular Synovitis and Prediction of Potential Diagnostic Markers Based on Bioinformatics.

Authors:  Jun Zhang; Bin Li; Boming Zhao; Yongjian Qi; Liaobin Chen; Jun Chen; Biao Chen
Journal:  Biomed Res Int       Date:  2022-06-07       Impact factor: 3.246

Review 2.  CSF-1R Inhibitor Development: Current Clinical Status.

Authors:  Florent Peyraud; Sophie Cousin; Antoine Italiano
Journal:  Curr Oncol Rep       Date:  2017-09-05       Impact factor: 5.945

3.  Arthroplasty for tenosynovial giant cell tumors.

Authors:  Floortje G M Verspoor; Gerjon Hannink; Anouk Scholte; Ingrid C M Van Der Geest; H W Bart Schreuder
Journal:  Acta Orthop       Date:  2016-06-30       Impact factor: 3.717

4.  Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors.

Authors:  F G M Verspoor; A Scholte; I C M van der Geest; G Hannink; H W B Schreuder
Journal:  Sarcoma       Date:  2016-12-26

Review 5.  Multifocal pigmented villonodular synovitis coexisting in both the knee joint and the patella: a case report and literature review.

Authors:  Mingxuan Gao; Hong Li; Xiaoyan Liang; Xiaoyan Fu; Xusheng Li
Journal:  BMC Musculoskelet Disord       Date:  2017-07-06       Impact factor: 2.362

6.  Higher incidence rates than previously known in tenosynovial giant cell tumors.

Authors:  Monique J L Mastboom; Floortje G M Verspoor; Arjan J Verschoor; Daniël Uittenbogaard; Banne Nemeth; Walter J B Mastboom; Judith V M G Bovée; P D Sander Dijkstra; H W Bart Schreuder; Hans Gelderblom; Michiel A J Van de Sande
Journal:  Acta Orthop       Date:  2017-08-08       Impact factor: 3.717

7.  Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor.

Authors:  F G M Verspoor; M J L Mastboom; G Hannink; R G Maki; A Wagner; E Bompas; J Desai; A Italiano; B M Seddon; W T A van der Graaf; J-Y Blay; M Brahmi; L Eberst; S Stacchiotti; O Mir; M A J van de Sande; H Gelderblom; P A Cassier
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

8.  Case Report: Extra-Articular Diffuse Tenosynovial Giant Cell Tumor of the Temporomandibular Joint.

Authors:  Xibiao Yang; Li Yao; Tianping Yu; Xiaoli Du; Qiang Yue
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

9.  Unusual manifestations of diffuse-type tenosynovial giant cell tumor in two patients: importance of radiologic-pathologic correlation.

Authors:  Ayca Dundar; Jason R Young; Doris E Wenger; Carrie Y Inwards; Stephen M Broski
Journal:  Skeletal Radiol       Date:  2019-10-28       Impact factor: 2.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.